Yutaka Fukuma

发表

Fisetin inhibits osteoclastogenesis through prevention of RANKL-induced ROS production by Nrf2-mediated up-regulation of phase II antioxidant enzymes.

H. Sakamoto, Y. Yamaguchi, E. Sakai, 2013, Journal of pharmacological sciences.

Genetic backgrounds and redox conditions influence morphological characteristics and cell differentiation of osteoclasts in mice

E. Sakai, T. Tsukuba, Shun Narahara, 2012, Cell and Tissue Research.

The coffee diterpene kahweol prevents osteoclastogenesis via impairment of NFATc1 expression and blocking of Erk phosphorylation.

H. Sakamoto, Y. Yamaguchi, E. Sakai, 2012, Journal of pharmacological sciences.

Rutaecarpine attenuates osteoclastogenesis by impairing M-CSF and RANKL-stimulated signaling pathways

E. Sakai, T. Tsukuba, Y. Fukuma, 2018 .

Inhibitory effects of tert‐butylhydroquinone on osteoclast differentiation via up‐regulation of heme oxygenase‐1 and down‐regulation of HMGB1 release and NFATc1 expression

H. Sakamoto, Y. Yamaguchi, E. Sakai, 2014, Journal of applied toxicology : JAT.

Suppression of RANKL‐dependent heme oxygenase‐1 is required for high mobility group box 1 release and osteoclastogenesis

M. Naito, K. Nakayama, E. Sakai, 2012, Journal of cellular biochemistry.

A disulfide bridge mediated by cysteine 574 is formed in the dimer of the 70-kDa heat shock protein.

T. Takagi, H. Itoh, T. Nemoto, 2006, Journal of biochemistry.

Effects of deficiency of Kelch‐like ECH‐associated protein 1 on skeletal organization: a mechanism for diminished nuclear factor of activated T cells cytoplasmic 1 during osteoclastogenesis

K. Itoh, Masayuki Yamamoto, M. Kido, 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

A comprehensive study on the immunological reactivity of the Hsp90 molecular chaperone.

T. Takagi, A. Mizuno, M. Shoji, 2004, Journal of biochemistry.

Deltamethrin inhibits osteoclast differentiation via regulation of heme oxygenase-1 and NFATc1.

H. Sakamoto, Y. Yamaguchi, E. Sakai, 2012, Toxicology in vitro : an international journal published in association with BIBRA.

Sanguiin H-6, a constituent of Rubus parvifolius L., inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis and bone resorption in vitro and prevents tumor necrosis factor-α-induced osteoclast formation in vivo.

Takashi Tanaka, E. Sakai, T. Tsukuba, 2016, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Cobalt protoporphyrin represses osteoclastogenesis through blocking multiple signaling pathways

E. Sakai, T. Tsukuba, M. Iwatake, 2015, BioMetals.

Identification of the pentapeptide constituting a dominant epitope common to all eukaryotic heat shock protein 90 molecular chaperones

A. Mizuno, T. Nemoto, J. Kishimoto, 2005, Cell stress & chaperones.

Rutaecarpine attenuates osteoclastogenesis by impairing macrophage colony stimulating factor and receptor activator of nuclear factor κ‐B ligand‐stimulated signalling pathways

E. Sakai, T. Tsukuba, K. Okamoto, 2018, Clinical and experimental pharmacology & physiology.

Dihydroartemisinin represses osteoclastogenesis of bone marrow macrophages through reduced NFATc1 expression and impaired phosphorylation of IκBα.

E. Sakai, T. Tsukuba, K. Okamoto, 2018, Biomedical research.

Cafestol has a weaker inhibitory effect on osteoclastogenesis than kahweol and promotes osteoblast differentiation.

E. Sakai, T. Tsukuba, K. Okamoto, 2015, BioFactors.